D.E. Shaw & Co’s Achillion Pharmaceuticals ACHN Stock Holding History

D.E. Shaw & Co’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-125,527	Closed	-$757K	–	4462
2019 Q4	$757K	Sell	125,527 -440,992	-78%	-$2.55M	﹤0.01%	3172
2019 Q3	$2.04M	Sell	566,519 -548,518	-49%	-$2.11M	﹤0.01%	2334
2019 Q2	$2.99M	Buy	1,115,037 +218,241	+24%	+$644K	﹤0.01%	1966
2019 Q1	$2.65M	Buy	896,796 +441,973	+97%	+$1.09M	﹤0.01%	1967
2018 Q4	$723K	Buy	454,823 +320,949	+240%	+$907K	﹤0.01%	2878
2018 Q3	$493K	Sell	133,874 -180,133	-57%	-$537K	﹤0.01%	3121
2018 Q2	$889K	Sell	314,007 -23,779	-7%	-$81K	﹤0.01%	2772
2018 Q1	$1.25M	Sell	337,786 -29,411	-8%	-$96.3K	﹤0.01%	2347
2017 Q4	$1.06M	Buy	367,197 +346,870	+1,706%	+$1.26M	﹤0.01%	2547
2017 Q3	$91K	Sell	20,327 -4,914	-19%	-$21.8K	﹤0.01%	3374
2017 Q2	$116K	Buy	+25,241	New	+$101K	﹤0.01%	3254
2016 Q4	–	Sell	-102,751	Closed	-$832K	–	3693
2016 Q3	$832K	Buy	102,751 +33,751	+49%	+$287K	﹤0.01%	2513
2016 Q2	$538K	Buy	69,000 +49,776	+259%	+$427K	﹤0.01%	2762
2016 Q1	$148K	Sell	19,224 -92,290	-83%	-$676K	﹤0.01%	3239
2015 Q4	$1.2M	Buy	111,514 +43,846	+65%	+$399K	﹤0.01%	2519
2015 Q3	$468K	Sell	67,668 -89,280	-57%	-$727K	﹤0.01%	3106
2015 Q2	$1.39M	Buy	156,948 +15,659	+11%	+$148K	﹤0.01%	2460
2015 Q1	$1.39M	Sell	141,289 -33,990	-19%	-$424K	﹤0.01%	2295
2014 Q4	$2.15M	Buy	175,279 +63,400	+57%	+$774K	﹤0.01%	2225
2014 Q3	$1.12M	Buy	111,879 +33,379	+43%	+$310K	﹤0.01%	2705
2014 Q2	$594K	Sell	78,500 -2,500	-3%	-$9.97K	﹤0.01%	3391
2014 Q1	$266K	Sell	81,000 -335,479	-81%	-$1.17M	﹤0.01%	3962
2013 Q4	$1.38M	Buy	416,479 +186,775	+81%	+$542K	﹤0.01%	2878
2013 Q3	$694K	Buy	229,704 +216,204	+1,602%	+$1.48M	﹤0.01%	3349
2013 Q2	$110K	Buy	+13,500	New	+$103K	﹤0.01%	3864